distinct clones of Fl-derived suppressor cells are restricted to each parental H-2 haplotype. Thus, Ts cells, like helper T cells, appear to be restricted in their ability to recognize antigen in the context of major histocompatibility complex gene products, but in the Ts pathway, antigen may be associated with I-J products instead of products of the I-A or I-E loci.
Materials and Methods
Mice. All mice were either purchased from The Jackson Laboratory, Bar Harbor, ME, or were bred in the animal facilities at Harvard Medical School, Boston, MA. Mice were used at 3-12 mo of age and were maintained on laboratory chow and acidified, chlorinated water ad lib. Antigens. NP-O-Succinimide (NP-O-Su) was purchased from Biosearch Co., San Rafael, CA. Dimethylsulfoxide (DMSO) was purchased from Fisher Scientific Co., Pittsburgh, PA. 2,4-dinitro-1-fluorobenzene (DNFB) was obtained from Eastman Kodak Co., Rochester, NY.
Antisera. Both B10.A(3R) anti-B10.A(5R) (anti-I-J k) and B10.A(5R) anti-B10.A(3R) (anti-
I-J b) were produced by immunization with spleen and lymph node cells as described elsewhere (14) . In Vitro Activation of NP-primed Lymph Node Tsa Cells with TsF2. Regional lymph node ceils from mice that had been immunized subcutaneously with 2 mg NP-O-Su were used as the source of Ts3 cells. B6-Tsz-28 and CKB-Ts2-59-derived TsF2, which have been characterized and described (13) , were used for activation of lymph node Tss cells in vitro. 5 × 107 NPprimed lymph node cells were cultured for 2 or 48 h in 10 ml RPMI 1640 with 10% fetal calf serum and 0.1 mM Hepes plus 50/~1 TsFz ascites fluid derived from B6-Tsz-28, CKB-Ts2-59, or BW5147 cells that were grown in (AKR × B6)F1, (AKR × CKB)F1, or AKR mice, respectively. After culture, these activated lymph node cells were washed three times with Hanks' balanced salt solution and resuspended.
Treatment of Lymph Node Cells with Anti-I-J Antisera and

Functional Analysis of the Activated NP-primed Lymph Node Ts3 Cells m Cyclophosphamide-treated
Antigen-primed Mice. Mice were primed subcutaneously with 2 mg of NP-O-Su in DMSO on day 0, as described elsewhere (15) . 24 h later, they were treated with an intraperitoneal injection of 20 m~/kg cyclophosphamide (CY) in saline. On day 6, each mouse received intravenously 1 × 10 NP-primed lymph node cells activated with TsF2 or control BW5147 factors, as described above, or received 0.5 ml of TsF2 or control BW5147 factors. Immediately after transfer, mice were challenged in the left footpad with 0.025 ml PBS solution containing 30 #g of NP-O-Su (prepared by mixing 25/d of a 2% NP-O-Su/DMSO solution in 0.4 ml PBS). Footpad swelling was measured 24 h later. Swelling was determined as the difference, in units of 10 -3 cm, between the left and right footpad thicknesS.' It should be noted that 1 × 107 immune lymph node cells are not sufficient to transfer immunity under these experimental conditions. DNFB Contact Sensitivity Responses. Contact sensitivity was induced by two daily paintings on the shaved abdomen with 25/~1 of 0.5% DNFB solution in acetone: olive oil (4:1) (16). 5 d after the last painting, 20/d of 0.2% DNFB in the same vehicle was applied to the left ear, and the ear swelling was measured as the difference between the left and right ear thicknesses. Double Antigen Ear Challenge. Individual mice were immunized with either DNFB alone or DNFB + NP-O-Su, as described above. Mice were challenged in the left ear by painting with 0.2% DNFB, injecting 0.015 ml containing 6/~g NP-O-Su (prepared by mixing 0.025 ml of 0.7% NP-O-Su in DMSO with 0.4 ml PBS, pH 7.7), or with both antigens. The incremental ear swelling was measured 24 h thereafter. The concentration and volume of NP-O-Su used to challenge was predetermined to elicit high specific ear swelling and low nonspeeifie backgrounds.
Percent Suppression. The percent suppression in the present study was calculated by the following formula: percent suppression = 100 x [(swelling of group receiving Tss cells activated with BW5147 tumor ascites -swelling of group receiving Ts3 cells activated with TsF2)/ (swelling of group receiving Tss cells activated with BW5147 tumor ascites -swelling of unprimed group)]. Data Analysis. Statistical analysis of the experimental data with respect to controls was calculated using the two-tailed Student's t test.
Results
In Vitro Activation of Tsa Cells.
To demonstrate that Ts2-derived factor could activate Tss cells, we took advantage of past observations on the biological properties of the Ts3 cell population. Thus, it was previously shown that the Ts3 population was sensitive to (CY) treatment and, furthermore, that lymph node cells from antigenprimed mice could be used in adoptive transfer experiments to restore Tss activity to the CY-treated recipients (4). To directly activate Tsz cells, we incubated 0.05 ml of BW5147 control or Ts2 hybridoma-derived ascites with 5 × 10 7 NP-O-Su-primed lymph node cells in 10 ml of RPMI 1640 media containing 10% fetal calf serum. The cells were cultured for 48 h at 37 ° in 10% CO2. After 48 h of in vitro culture, the cells were washed extensively, and 1 X 107 viable lymph node cells were injected intravenously into syngeneic recipients that had been previously primed with NP-O-Su and treated 24 h later with 20 mg/kg CY. In confirmation of previous findings (5), CYtreated recipients were not sensitive to suppression by monoclonal B6-Ts2-28 or CKBTs2-59 suppressor factor (Table I) . However, significant suppression of the cutaneous sensitivity (CS) response was observed when CY-treated recipients were given lymph node cells derived from NP-O-Su-primed C57BL/6 mice that were activated in vitro with B6-Ts2-28-derived TsF2. As specificity controls, factors from the BW5147 tumor line or from the CKB-Ts2-59 line failed to activate suppressive activity in these cells. The failure of CKB-Ts2-59-derived TsF2 to activate C57BL/6 antigen-primed lymph node cells is presumably due to the H-2-1inked (I-J) genetic restriction of TsF2 (13) . Thus, the B6-Ts2-28 factor that is derived from C57BL/6 (H-2 b, Igh b) cells is only active in recipients that are matched at the I-J and Igh regions (13) . The CKB-Ts2-59 factor is of CKB (H-2 k, Igh b) origin and is also genetically restricted by I-J and Igh genes. To verify that the CKB-Ts2-59 factor was capable of activating antigen-primed lymph node cells of the appropriate strain, a reciprocal experiment was performed. As shown in Table I , the CKB-Ts~-59 factor activated Tsz suppressive activity when incubated with H-2 and Igh-matched B10.BR lymph node cells, whereas the C57BL/6-derived Ts2 factor failed to induce suppression under the same experimental conditions.
Kinetics of Tss Activation. Lymph node cells from C57BL/6 mice were cultured with B6-Ts2-28 or control BW5147-derived factors for various intervals ranging from 5 rain to 48 h. The cells were then washed and assayed for suppressive activity in NP-O-Suprimed CY-treated C57BL/6 recipients. As shown in Fig. 1 was evaluated in two ways. First, NP-O-Su or DNFB antigen-primed C57BL/6 lymph node cells were used as the source of Tsa cells for activation with TsFz. Second, these activated cells were tested for suppressive activity in syngeneic C57BL/6 recipients primed with either DNFB or DNFB + NP-O-Su. In these experiments the mice were challenged by injection of NP-O-Su into the left ear pinna or by painting the left ear with DNFB or both. The control right ear was untreated. As shown in Table II , the only condition in which significant levels of suppression were observed was when hybridoma-derived TsF2 was used to activate Tss cells from NP-O-Su-primed mice and when these activated Tsa cells were tested in animals primed and challenged with NP-O-Su. The suppression was not due to the carry over of B6-Ts2-28 factor because intravenous injection of TsF2 did not suppress CY-treated recipients (Table II) . NPspecific TsF2 would not activate lymph node cells from DNFB-primed mice, even when these cells were tested in DNFB-primed and challenged recipients. Furthermore, there is no apparent suppression of a bystander DNFB response when activated Tss cells are transferred to recipients that had been either doubly primed or challenged with DNFB + NP-O-Su (Table II) . Tsa cells to antigen-primed CY-treated C57BL/6, B10.BR, CKB, or C3H recipients. Activated Tss cells were transferred during the effector phase of the CS response, i.e., on the day of antigen challenge. Such effector phase transfers minimize potential allogeneic effects because the Tsn cells are only present in the allogeneic environment for 24 h before termination of the assay. Furthermore, the BW5147-activated Ts3 lymph node population serves as a control for nonspecific suppression. The data shown in Table III were derived from seven independent experiments that were normalized and pooled. Activation of the Ts3 population was generally assayed after 2 h of incubation with TsF2. After activation of the Tsz-containing lymph node population, suppressive activity was only noted in combinations of TsF2, Ts3, and recipients that were matched at the H-2 and Igh gene complexes. Thus, after a 2 h in vitro activation, C57BL/6 (H-2b)-derived TsF~ activated C57BL/6 but not B10.BR 
Genetic Restrictions on
* In vitro activation of regional lymph node Tsz cells from NP-O-Su-primed mice with TsF2 was done as described in Materials and Methods. Activation was continued for 2 h except for one experiment in which a 48-h activation was used. Recipient mice were primed with NP-O-Su; 24 h later all mice were given 20 mg/kg cyclophosphamide, and 6 d later received 1 × 107 activated Ts3 before antigen challenge. The data represent the pooled results from seven separate experiments (not all groups were included in each experiment). The data were normalized and the percent suppression + SE was calculated. The number of mice is indicated in parentheses. $ Significant suppression, P < 0.01.
(H-2 k) Tsa cells that only functioned when adoptively transferred to syngeneic C57BL/6 recipients. Similarly, after 2 h of activation with CKB (H-2k)-derived TsFs, only B10.BR or CKB Ts3-containing lymph node cells were activated. Furthermore, the activated B10.BR or CKB Tss population would suppress CS responses in H-2 and Igh-matched B10.BR and CKB recipients but not in Igh-disparate C3H mice (Table III) . To prove that the suppression was mediated by activated Tsa cells instead of TsF2 that might have been passively transferred along with the Tss cells, we injected TsF~ intravenously into NP-O-Su-primed (3Y-treated recipients. As shown in Table  III , administration of TsF2 without added Tss cells was unable to suppress CS responses in antigen-primed (3Y-treated recipients.
I-J Restriction of Activated Ts~
Because after a 2-h activation period the TsFa-Tsatarget cell interactions are H-2 restricted, we next asked which subregion within the H-2 complex was responsible for this genetic restriction. Based on several previous studies that indicated that suppressor cell restrictions were generally mediated through the I-J subregion (5, 13, 17), we tested two congenic strains of mice, 3R(I-J b) and 5R(I-Jk), that only differ with respect to their I-J subregions. The data in Table IV demonstrate that using 2-h activation conditions, suppression is only observed when the TsFs-Ts3 and the recipient strain are matched at the I-J subregion. The controls for these experiments were similar to those used in the previous experiments and demonstrate that the results are not due to carry over of TsF2 (Table IV) . The simplest hypothesis that would account for the above observation is that two distinct Tsa populations exist in lymph node cells derived from F1 animals; one population is restricted by I-J b gene products and the other by I-J k gene products. This hypothesis parallels the situation observed with helper T cells derived from F1 mice in which two functionally distinct populations exist and each is restricted by different I region genes (18, 19) . Another possibility to account for these observations is that the I-J gene products are allelically expressed on the F1 cells. To test the latter possibility, B10.BR, C57BL/6, or (B10 × B10.BR)Fa NP-O-Su-primed lymph node cells were treated with anti-I-J k or anti-I-J b alloantisera plus complement before a 2-h activation with TsF2. As shown in Table VI Table VII , significant suppression was only noted when the TsF2 and Ts3 cells were derived from strains that shared H-2 haplotypes. It should be noted that after a 2-h activation, CKB (H-2k)-derived TsF~ failed to activate C57BL/6 (H-2 b) Ts3 cells, even when the potential suppressive activity of these cells was assayed in H-2 b X H-2 k recipients. These data again indicate that under these experimental conditions a definite requirement for H-2 homolgy exists among the TsF2, Ts3 cells and the recipient strain.
Activation and Function of Ts3 Cells Derived from F1 Mice. To further analyze the
Suppression of H-2 Heterozygous F1 Recipients by Activated Tsa Cells. Finally, to evaluate
In a second experiment, the role of genes linked to the Igh complex was also evaluated. Thus, C57BL/6 (H-2 b, Ighb), CKB (H-2 k, Ighb), and C3H (H-2 k, Igh j) Ts3 cells were activated for 2 h with either C57BL/6-or CKB-derived TsF2. The activated cells were then adoptively transferred to (C57BL/6 × CBA)F1 (H-2b/H-2k; Ighb/Igh j) recipients during the effector phase of the CS response. Only in those combinations Table III for in which the donor of the TsF2, the Tsa, and the recipients shared genes in both the H-2 and Igh complexes were significant levels of suppression noted (Table VII) .
Discussion
The past several years have witnessed numerous advances in our knowledge of the mechanisms of immunoregulation. In some systems, three distinct T lymphocyte subpopulations act in a defined sequence to mediate immune suppression (20, 21) . For example, suppression of both cellular (5) and humoral (7) immune responses to the NP require a similar cellular cascade involving Tsl, Ts2, and Tss cells as well as factors derived from each of these cell types. Previous reports (5, 13, 16) from our laboratory characterized a series of hybridoma T cell lines representing each of these functional populations. Furthermore, we compared the suppressor factors (TsF) released by each of these Ts cells. The TsF2 and TsFa factors, which both function during the effector phase of the immune response, have similar genetic restrictions. Thus, TsF2 and TsFs only suppress strains of mice that are homologous with the factor-producing strain at both the H-2 complex (I-J subregion) and the Igh complex (5, 13) . Because the basis for these dual restrictions had not been clarified, it was postulated that at least some of the restrictions might represent "pseudogenetic restrictions," as were initially described for TsF1 factors and cells (16, 22, 23) . These pseudogenetic restrictions reflect requirements for homology between H-2 or Igh determinants that are present at different ends of the suppressor cell cascade (16) . The hypothesis that the dual genetic restrictions of TsFz reflected a psuedo-restriction was based on the observation that TsF2 activity could be absorbed by Tsa cells derived from mice of different H-2 haplotypes (13). The present protocol was designed to determine whether the allogeneic cells that could absorb TsF2 could become activated. Thus, we developed an experimental system in which the genetics of activation of Ts8 cells by TsF2 could be analyzed in vitro, independent of the ability of activated Ts3 cells to interact with their targets. The transfer of Ts3 cells was performed during the effector phase, i.e., along with the NP-O-Su challenge and within 24-26 h of the termination of the CS response, to minimize potential allogeneic effects. Additional controls to exclude potential allogeneic affects included the transfer of nonactivated Tss cells that were cultured with control BW5147-derived factor. Furthermore, F1-derived Ts3 cells and F1 recipients were used in combinations in which the direction of the allogeneic effect could be controlled (Tables V and VII) .
The data demonstrated that NP-specific Tsa ceils are generated in NP-O-Suimmune animals concomitant with the CS effector cell population. In contrast to CS effector cells, Tsz are very sensitive to low dose CY treatment. The Tsz cells must be specifically activated by TsFz to manifest suppression (Table I) . Normally, in a primary NP-O-Su immune response, the Ts3 ceils are not activated. However, later in the response the Tsz cells may play an important immunoregulatory role in modulating both the cellular and humoral immune response (4, 7) . The present data directly demonstrate the role of TsF2 in suppressor cell activation. The triggering of Tsa cells with TsF2 is rapid. Thus, after 1-2 h of in vitro exposure to TsF2, the activation of Ts3 cells appears irreversible and results in optimum levels of suppression (Fig. 1) . This rapid activation process presumably reflects the fact that the antigen-primed Tsa cells have already expanded and differentiated. These cells apparently await a terminal signal for activation and/or release of biologically active mediators, such as TsF3.
The specificity of Ts3 cell-mediated suppression was demonstrated in two ways. First, NP-specific Tsz cells are generated after NP-O-Su priming, whereas immunization with another antigen (e.g., DNFB) does not generate NP-reactive Tsz cells. Furthermore, once NP-O-Su-induced Ts3 ceils are activated with TsF2, they suppress only NP-O-Su-induced CS responses even in animals that have been doubly primed or challenged with NP-O-Su plus DNFB (Table II) . Although under the experimental conditions described in this report immune suppression is antigen specific, nonspecific suppression of immune response has been noted in other systems in which different experimental conditions are used (10) (11) (12) . This disparity might reflect the requirement for the suppressor cell and the potential targets to be in very close proximity to mediate suppression.
Genetic analyses of the TsF2-Tsa-target cell interaction indicated the requirement for Igh homology was absolute. Thus, CKB (Ighb)-derived TsF2 would only activate an Igh-compatible Tsa population, which in turn only suppressed Igh homologous recipients (Table III) . These results, along with previous data (24) demonstrating anti-idiotypic receptors on Tsz cells and factors as well as previous data demonstrating the presence of Npb-related idiotypic determinants on TSl and Ts3 cells, suggests that suppressor T cell interactions proceed via a series of idiotypic-anti-idiotypic interactions in accord with Jerne's network hypothesis. In addition to the absolute requirement for Igh homology with respect to the cells involved in suppression of the effector phase of the contact sensitivity response, there also is an H-2 restriction that controls the interaction of these cells. Thus, after activation, the series of interactions between TsF2, Tsa, and the recipient strain appears to be completely H-2 restricted. These H-2 restrictions can be more precisely mapped to the I-J subregion of the H-2 complex (Table IV) , which has also been shown to regulate suppressor cell interactions in other systems (17, 25, 26) . The physiological meaning of this I-J restriction is unknown. We have not yet determined the directionality of the restriction; i.e., do Ts3 cells have a receptor for I-J determinants on a target population or are the I-J determinants present on Tsa cells and factors recognized by the target population?
To further evaluate the genetic restrictions on activated Tss cells, (B 10 × B 10.BR)F1 hybrid-derived Tss were cultured with either H-2 b-or H-2k-derived TsF2, and the activated Tsa were tested for suppressive activity in either C57BL/6 (H-2 b) or B 10.BR (H-2 k) recipients. The data again demonstrate that the critical requirements for H-2 homology were between the H-2 type of the TsF2 donor and the H-2 type of the recipients of activated Ts3 cells. Thus, a C57BL/6-derived TsF2 activated (B10 X B 10.BR)Fl-derived Ts3 cells, as evidenced by their ability to suppress NP-induced CS responses in C57BL/6 mice. It should be noted that the same population of activated Tss cells failed to suppress NP-O-Su CS responses in B10.BR recipients (Table V) . Reciprocal data were obtained when CKB-derived TsF2 was used to activate Faderived Ts3 cells (Table V) . The simplest explanation for these observations is that two distinct populations of Tsa cells exist in heterozygous Fa donors, each restricted to a parental I-J determinant. This hypothesis is analogous to the findings noted with Fl-derived helper T cells (18, 19) . By extending this analogy with helper T cells further, one can postulate that the induction of I-J restrictions might reflect the requirement for the initial presentation of antigen in the context of I-J determinants. Preliminary experiments support the latter postulate.
The next series of experiments was aimed at determining whether I-J determinants were allelically excluded in the H-2 heterozygous Ts3 population. If only one I-J determinant was expressed on each subset of Fl-derived Ts3 cells, it could help to explain the directionality of the genetic restriction. The data in Table VI clearly demonstrate that these I-J determinants are not allelically excluded in confirmation of the results reported by Okuda et al. (27) , who arrived at similar conclusions in a different type of experimental system. However, because both I-J determinants are expressed on Ts3 cells of F1 origin, it will be important to analyze TsFs of F1 origin to determine whether both I-J determinants are also present on these factors. Separate experiments are planned to address these questions.
Finally, we evaluated the role of the recipient strain in these genetic restrictions. By using F1 recipients, we again confirmed the requirements for homology at both H-2 and Igh complexes. The recipient strain must contain the cells that are the target of the activated Tss population. However, the present data do not permit us to determine the nature of these target cells. The target cells could be the CS effector cells, a Ts4 population, or even an antigen-presenting cell. Whatever the nature of the target, we expect that it will either bear I-J determinants or receptors for I-J, and it may also bear anti-idiotypic receptors. Furthermore, the data obtained after a 2-h activation argue against the notion that the dual genetic restrictions of TsF2 and TsFa are pseudogenetie restrictions, as were defined for Tsl-derived factors (16, 22, 23) . In addition, some experimental data indicate that TsF3 may have a two-chain structure, one polypeptide containing I-J determinants and the other idiotypic determinants (28) (Furusawa, et al., unpublished data). The dual genetic restriction of Tsa cells and factors might therefore reflect the requirement of target cells to interact with both portions of the TsFa molecule. The significance of these dual restrictions (I-J and Igh) might lie in the fact that two recognition signals are required for the activation of effector-suppressor cells. Such a two-signal model could account for the specifcity of suppression as well as the molecular structure of the factor.
Summary
An experimental system was developed to independently analyze the H-2 and Igh genetic restrictions at two steps of the 4-hydroxy-3-nitrophenylacetyl hapten (NP) suppressor cell pathway. This experimental system allowed genetic analysis of the activation of Ts8 cells by hybridoma-derived TsF2 and independent analysis of the genetic restrictions that controlled the interaction of the Ts3 cells with their target population. Thus, Ts~ cells were activated in vitro with monoclonal H-2 b or H-2 kderived TsF2. The activated Tsa cells were then adoptively transferred to Ts3-depleted (cyclophosphamide-treated) recipients of various genotypes. When the Tsa-containing lymph node population was activated in vitro for 2 h, suppressive activity was only noted in combinations of TsF2, Tss, and recipients that were matched at both the I-J and Igh gene complexes. The data indicate that TsF2 can activate Tsa cells and that both the activation and the interaction of Tss cells are I-J and Igh restricted. Using (B10 X B10.BR)F1 mice as Tsa donors, we noted that H-2b-derived TsF2 activated these Fz Tsa cells to suppress NP-specific cutaneous sensitivity responses in H-2 b but not in H-2 k recipients. Reciprocal experiments using H-2k-derived TsF2 demonstrated that only an H-2k-restricted population was activated in the Frderived Tsa cells. The simplest explanation to account for these observations is that two distinct populations, each of which is restricted to a parental I-J determinants, exists in the heterozygous Fz Tss population. Furthermore, we demonstrated that both I-J b and I-J k determinants are expressed on Frderived Tsa cells. These observations are discussed in terms of the mechanisms involved in immunoregulation.
